drugset / Trial / NCT05881811
The Drug-drug Interaction of HSK16149 Capsule With Probenecid Tablets or Cimetidine Tablets in Healthy Subjects
RandomizedCrossoverOpen-labelOther
Summary
This study is a single-center, open-label, crossover study, conducted in healthy Chinese populations, and plans to enroll 48 healthy adult subjects (male and female).
Timeline
- Start
- 2023-03-20
- Primary completion
- 2023-04-24
- Completion
- 2023-06-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cimetidine | Small molecule | 200 mg | — |
| Subject | HSK16149 | Unknown | 40 mg | — |
| Subject | Probenecid | Small molecule | 500 mg | — |